OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Pact between CPI and Cambridge Design Partnership aims to streamline the innovation-to-commercialization journey
CPI, which works with companies to turn inventions into products and processes that help increase health and wellbeing, and Cambridge Design Partnership (CDP), a technology and product design partner, have established a global alliance focused on extending the potential of diagnostic and healthcare technologies. They will hope to achieve this by providing commercial readiness and offering UK leadership in medical technologies.
UK-based CPI is an independent deep-tech innovation center. Its objective is to guide organizations through their innovation journey by connecting them to a personalized group of experts, innovation development facilities, funding support and specialty innovation tools, with the aim of contributing ideas and research into the market.
The partnership enhances the competences of both businesses. CDP gains access to CPI’s specialist expertise and capabilities in development and business scale-up. As a result, it can accelerate its client projects to market-seeding volumes, the parties note. Projects at CPI benefit from CDP's GMP (good manufacturing practice) and ISO 13485 certified quality management system, ensuring compliance with relevant legislation and standards.
The two groups plan to shape early stage innovation into investment-ready business cases and market-ready products. This will potentially help speed up the development of products and technologies, providing value to patients within clinical areas, including infectious disease and oncology. One specific goal is to expand upon the impact of the UK’s scientific and technology research base, improving the path to not only commercialization but the clinic as well.